D. H. Osmond

1.4k total citations · 1 hit paper
41 papers, 1.1k citations indexed

About

D. H. Osmond is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, D. H. Osmond has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in D. H. Osmond's work include Renin-Angiotensin System Studies (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers) and Receptor Mechanisms and Signaling (9 papers). D. H. Osmond is often cited by papers focused on Renin-Angiotensin System Studies (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers) and Receptor Mechanisms and Signaling (9 papers). D. H. Osmond collaborates with scholars based in Canada, Russia and Netherlands. D. H. Osmond's co-authors include Susan R. George, Brian F. O’Dowd, Dennis K. Lee, Regina Cheng, Theresa Fan, Yang Liu, Tuan Nguyen, Anula Kariyawasam, V. E. Valli and Reuben Baumal and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Hypertension.

In The Last Decade

D. H. Osmond

40 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of Apelin, the Ligand for the APJ Receptor

2000 587 citations Dennis K. Lee, Regina Cheng et al. Journal of Neurochemistry profile →

Peers

D. H. Osmond

PHARM

SURGE

CCM

CMN

EDM

Marie Buléon France

Oliver Domenig Austria

Mark C. Chappell United States

Liliya M. Yamaleyeva United States

Michiaki Okumura Japan

Nancy T. Pirro United States

Scott M. MacKenzie United Kingdom

V. Maxwell United States

Brian Westwood United States

J. B. Field United States

Marie Buléon France

D. H. Osmond

344 ×0.6

PHARM

249 ×0.5

SURGE

179 ×0.5

CCM

113 ×0.4

CMN

101 ×0.4

EDM

Citations per year, relative to D. H. Osmond D. H. Osmond (= 1×) peers Marie Buléon

Countries citing papers authored by D. H. Osmond

Since Specialization

Citations

This map shows the geographic impact of D. H. Osmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. H. Osmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. H. Osmond more than expected).

Fields of papers citing papers by D. H. Osmond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. H. Osmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. H. Osmond. The network helps show where D. H. Osmond may publish in the future.

Co-authorship network of co-authors of D. H. Osmond

This figure shows the co-authorship network connecting the top 25 collaborators of D. H. Osmond. A scholar is included among the top collaborators of D. H. Osmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. H. Osmond. D. H. Osmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simos, Demetrios, et al.. (2009). Angiotensin converting enzyme-regulated, noncholinergic sympathoadrenal catecholamine release mediates the cardiovascular actions of human ‘new pressor protein’ related to coagulation beta-factor XIIa. Canadian Journal of Cardiology. 25(4). e100–e108. 3 indexed citations

Pourdjabbar, Ali, et al.. (2004). Are cardiovascular and sympathoadrenal effects of human “new pressor protein” preparations attributable to human coagulation β-FXIIa?. American Journal of Physiology-Heart and Circulatory Physiology. 286(3). H837–H846. 6 indexed citations

Boomsma, Frans, et al.. (2004). Role of bradykinin B2-receptor in the sympathoadrenal effects of ???new pressor protein??? related to human blood coagulation factor XII fragment. Journal of Hypertension. 22(6). 1173–1181. 6 indexed citations

Pearl, Rachel, et al.. (2003). Possible role of new pressor protein in hypertensive anephric hemodialysis patients. Pediatric Nephrology. 18(10). 1025–1031. 6 indexed citations

Lee, Dennis K., Regina Cheng, Tuan Nguyen, et al.. (2000). Characterization of Apelin, the Ligand for the APJ Receptor. Journal of Neurochemistry. 74(1). 34–41. 587 indexed citations breakdown →

Osmond, D. H., et al.. (1998). Potent ʼnew pressor proteinʼ related to coagulation factor XII is potentiated by inhibition of angiotensin converting enzyme. Journal of Hypertension. 16(3). 311–320. 7 indexed citations

Grodecki, Kajetan, et al.. (1997). Treatment of X-linked hereditary nephritis in samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. Journal of Comparative Pathology. 117(3). 209–225. 81 indexed citations

Ng, Gordon, Ruoxiang Wang, P.H. Wu, et al.. (1994). The identification of NP25: a novel protein that is differentially expressed by neuronal subpopulations. Molecular Brain Research. 22(1-4). 173–185. 40 indexed citations

Osmond, D. H., Jean E. Sealey, & J. K. McKenzie. (1991). Activation and function of prorenin: different viewpoints. Canadian Journal of Physiology and Pharmacology. 69(9). 1308–1314. 14 indexed citations

10.

Ιωάννου, Πέτρος, et al.. (1991). Activation and measurement of plasma prorenin in the rat. Canadian Journal of Physiology and Pharmacology. 69(9). 1331–1340. 8 indexed citations

11.

Hare, Gregory M. T. & D. H. Osmond. (1990). New Renin – Angiotensin From Plasma Prorenin?. American Journal of Hypertension. 3(3). 196–203. 1 indexed citations

12.

Hare, Gregory M. T., et al.. (1989). Extrarenal production and activation of human plasma prorenin: the evidence after venous occlusion. Canadian Journal of Physiology and Pharmacology. 67(1). 59–67. 3 indexed citations

13.

Ιωάννου, Πέτρος, et al.. (1989). Does Angiotensin Regulate Systemic Conversion of Prorenin to Renin?. Clinical and Experimental Hypertension Part A Theory and Practice. 11(7). 1273–1300. 5 indexed citations

14.

Osmond, D. H., et al.. (1986). Evidence for -Adrenergic Regulation of Renal and Extrarenal Plasma Prorenin and Renin in Dogs. Experimental Biology and Medicine. 182(2). 208–214. 2 indexed citations

15.

Osmond, D. H., et al.. (1982). Peculiarities of Plasma “Prorenin” Measurements in Man, Dog, and Rat, and Their Theoretical Implications. Clinical and Experimental Hypertension Part A Theory and Practice. 4(11-12). 2213–2230. 9 indexed citations

16.

Cybulsky, Andrey V., D.W.G. Cox, & D. H. Osmond. (1980). Activation of prorenin by proteases from polymorphonuclear leukocytes. Canadian Journal of Physiology and Pharmacology. 58(4). 406–410. 4 indexed citations

17.

Osmond, D. H., et al.. (1978). Microheterogeneity and sialic acid in human plasma angiotensinogens in various physiological states. Canadian Journal of Biochemistry. 56(9). 892–899. 8 indexed citations

18.

Osmond, D. H., et al.. (1978). KALLIKREIN AND PLASMIN AS ACTIVATORS OF INACTIVE RENIN. The Lancet. 312(8104). 1375–1376. 41 indexed citations

19.

Osmond, D. H., et al.. (1974). Renin activity by radioimmunoassay: The plasma incubation step. Clinical Biochemistry. 7(1-4). 52–63. 26 indexed citations

20.

Osmond, D. H.. (1972). Renal weight and content of lipids and phospholipid renin "preinhibitor" in rats with renal hypertension.. PubMed. 80(6). 755–64. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact